Summary

The Europe bioanalytical testing services market was valued at US$ 1,374.48 million in 2022 and is expected to reach US$ 2,956.96 million by 2030; it is estimated to grow at a CAGR of 10.0% from 2022 to 2030.

High Demand for Analytical Testing of Biosimilars and Biologics Fuel the Europe Bioanalytical Testing Services Market

Biologics are among the most promising therapeutic areas important in the pharmaceutical market. The rising number of cases of chronic diseases such as inflammatory bowel diseases, cancer, and rheumatoid arthritis propels the demand for biologics. However, the high cost of biologics' has redirected the focus of drug developers and healthcare stakeholders toward biosimilars in recent years. Additionally, the imminent expiry of the patents and exclusivity periods of biologics have also created opportunities for the development of biosimilars. According to McKinsey & Co., ~19 high-volume biologics would lose exclusivity by 2025. Additionally, 39 more high-volume biologics are expected to lose patent protection between 2026 and 2032, with more biologics likely to follow. The Association for Accessible Medicines (AAM) expects a ~25% price drop on branded biologics on average after the launch of biosimilars because average biosimilar sales prices are ~50% lower than the original branded biologics.

The anticipated rise in biosimilar R&D would boost the demand for related bioanalytical testing services-compatibility studies for biosimilars, stability testing, product release testing, and biosimilar protein analysis-to reduce the risks involved with medication development. Thus, the rise in demand for analytical testing of biosimilars is boosting the growth of the bioanalytical testing services market.

Europe Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region occupies a significant position in the global bioanalytical testing services market. The European bioanalytical testing services market is expected to witness significant growth during the forecast period due to the strong manufacturing capabilities in the pharmaceutical, biopharmaceutical, and biotechnological industries, and the presence of leading bioanalytical testing service providers in different European countries.

Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Europe Bioanalytical Testing Services Market Segmentation

The Europe bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Europe bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Europe bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Europe bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Europe bioanalytical testing services market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, KCAS Bioanalytical and Biomarker Services LLC, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Europe bioanalytical testing services market.

ページTOPに戻る

Table of Contents

Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioanalytical Testing Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
5. Europe Bioanalytical Testing Services Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
5.2.1 Challenges in Development and Validation of Bioanalytical Methods
5.3 Key Market Opportunities
5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:
6. Bioanalytical Testing Services Market - Europe Market Analysis
6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
7. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
7.3.1 Overview
7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
7.4.1 Overview
7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
7.5.1 Overview
7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
7.6.1 Overview
7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 In-Vitro Virology Testing
7.6.2.1.1 Overview
7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6.3 In-Vivo Virology Testing
7.6.3.1 Overview
7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
7.7.1 Overview
7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication
8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
8.3.1 Overview
8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
8.4.1 Overview
8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
8.7.1 Overview
8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
8.8.1 Overview
8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
8.9.1 Overview
8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
8.10.1 Overview
8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
9.4.1 Overview
9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development and Manufacturing Organization (CDMO)
9.5.1 Overview
9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Bioanalytical Testing Services Market - Country Analysis
10.1 Europe Bioanalytical Testing Services Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Europe Bioanalytical Testing Services Market by Country
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Germany Bioanalytical Testing Services Market, by Services
10.1.1.2.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
10.1.1.2.4 Germany Bioanalytical Testing Services Market, by Disease Indication
10.1.1.2.5 Germany Bioanalytical Testing Services Market, by End User
10.1.1.3 UK
10.1.1.3.1 Overview
10.1.1.3.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 UK Bioanalytical Testing Services Market, by Services
10.1.1.3.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
10.1.1.3.4 UK Bioanalytical Testing Services Market, by Disease Indication
10.1.1.3.5 UK Bioanalytical Testing Services Market, by End User
10.1.1.4 France
10.1.1.4.1 Overview
10.1.1.4.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 France Bioanalytical Testing Services Market, by Services
10.1.1.4.3.1 France Bioanalytical Testing Services Market, by Virology Testing
10.1.1.4.4 France Bioanalytical Testing Services Market, by Disease Indication
10.1.1.4.5 France Bioanalytical Testing Services Market, by End User
10.1.1.5 Italy
10.1.1.5.1 Overview
10.1.1.5.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Italy Bioanalytical Testing Services Market, by Services
10.1.1.5.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
10.1.1.5.4 Italy Bioanalytical Testing Services Market, by Disease Indication
10.1.1.5.5 Italy Bioanalytical Testing Services Market, by End User
10.1.1.6 Spain
10.1.1.6.1 Overview
10.1.1.6.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Spain Bioanalytical Testing Services Market, by Services
10.1.1.6.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
10.1.1.6.4 Spain Bioanalytical Testing Services Market, by Disease Indication
10.1.1.6.5 Spain Bioanalytical Testing Services Market, by End User
10.1.1.7 Rest of Europe
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Europe Bioanalytical Testing Services Market, by Services
10.1.1.7.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
10.1.1.7.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
10.1.1.7.5 Rest of Europe Bioanalytical Testing Services Market, by End User
11. Bioanalytical Testing Services Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 SGS SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Syneos Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 KCAS Bioanalytical and Biomarker Services LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ICON Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Intertek Group Plc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms